Herbalife (NYSE:HLF - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Sunday, Wall Street Zen reports.
Several other research analysts have also recently weighed in on the company. UBS Group set a $21.00 price target on Herbalife in a research report on Thursday, September 17th. Weiss Ratings cut shares of Herbalife from a "hold (c+)" rating to a "hold (c)" rating in a research note on Friday, July 24th. Citigroup reaffirmed a "buy" rating and set a $17.00 target price (down from $21.00) on shares of Herbalife in a report on Friday, August 7th. Finally, Texas Capital raised shares of Herbalife to a "strong-buy" rating in a report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Herbalife currently has an average rating of "Moderate Buy" and an average price target of $17.67.
Read Our Latest Report on HLF
Herbalife Trading Up 2.9%
Shares of HLF opened at $12.57 on Friday. The company has a market capitalization of $1.32 billion, a PE ratio of 8.11, a price-to-earnings-growth ratio of 0.42 and a beta of 0.85. The business's 50 day moving average is $12.19 and its 200 day moving average is $13.25. Herbalife has a 12-month low of $7.56 and a 12-month high of $20.40.
Herbalife (NYSE:HLF - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.54 by ($0.03). The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.31 billion. Herbalife had a net margin of 3.16% and a negative return on equity of 43.90%. Herbalife's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.59 earnings per share. Equities research analysts predict that Herbalife will post 2.68 earnings per share for the current year.
Herbalife declared that its board has authorized a stock repurchase program on Tuesday, September 8th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to reacquire up to 19.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.
Hedge Funds Weigh In On Herbalife
Hedge funds have recently made changes to their positions in the company. Arrowstreet Capital Limited Partnership boosted its stake in shares of Herbalife by 11.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,596,795 shares of the company's stock worth $38,225,000 after acquiring an additional 267,539 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Herbalife by 29.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company's stock worth $27,638,000 after purchasing an additional 425,968 shares in the last quarter. Invenomic Capital Management LP lifted its stake in Herbalife by 82.6% in the 4th quarter. Invenomic Capital Management LP now owns 768,031 shares of the company's stock worth $9,900,000 after purchasing an additional 347,401 shares in the last quarter. Pacer Advisors Inc. acquired a new position in shares of Herbalife during the 1st quarter worth approximately $9,491,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Herbalife in the second quarter valued at approximately $5,842,000.
About Herbalife
(
Get Free Report)
Herbalife Ltd. NYSE: HLF is a global nutrition and wellness company that develops and sells products through a network of independent distributors. Its offerings are designed to support weight management, balanced nutrition, energy, sports performance and personal care.
The company's product portfolio includes meal-replacement shakes, protein and fiber products, dietary supplements, vitamins, herbal teas, sports nutrition products and skin- and body-care items. Herbalife distributes its products in markets around the world, including North America, Latin America, Europe, Asia-Pacific and Africa, primarily through direct selling and independent members who provide product information and personalized support to consumers.
Herbalife was founded in 1980 by Mark Hughes and has since expanded from a primarily weight-management business into a broader nutrition and wellness enterprise.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.